Does permanent pacemaker implantation after TAVR increase the risk of mortality and heart failure-related rehospitalization?
Permanent pacemaker implantation after TAVR is associated with increased late mortality and heart failure rehospitalization, emphasizing the importance of procedural techniques that minimize conduction system injury.
Patients who undergo PPI after TAVR experience higher risk of mortality and HF-related rehospitalization over time. These findings provide support for the implementation of procedural strategies to prevent heart conduction disorder and, thus, avoid PPI at the time of TAVR.
Sá et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: